Key distinction: HPG-stimulating peptides vs exogenous testosterone

Peptides that stimulate the HPG axis increase endogenous testosterone while maintaining testicular function and spermatogenesis. Exogenous testosterone (TRT) suppresses LH/FSH → shuts down Leydig cells → reduces intratesticular testosterone → impairs spermatogenesis. These are mechanistically opposite approaches — both are research tools for different questions.

Why kisspeptin-10 is the most direct testosterone-stimulating peptide

Kisspeptin-10 activates KISS1R on GnRH neurons → GnRH pulse within minutes → LH surge → Leydig cell testosterone synthesis. The entire cascade from kisspeptin-10 injection to peak testosterone elevation occurs within 30-60 minutes. This makes kisspeptin-10 the most pharmacologically precise tool for studying HPG axis activation — more direct than GnRH itself (which requires pulsatile delivery to avoid receptor desensitisation).

HCG bypasses the entire HPG axis

HCG (human chorionic gonadotropin) directly activates the LH receptor on Leydig cells — bypassing hypothalamic GnRH and pituitary LH entirely. This makes HCG the tool for studying Leydig cell testosterone synthesis in isolation, and for maintaining intratesticular testosterone (ITT) during exogenous testosterone (TRT) administration that suppresses endogenous LH.

Do peptides increase testosterone?

Several research peptides stimulate endogenous testosterone production: kisspeptin-10 (KISS1R → GnRH → LH → Leydig testosterone), HCG (direct LH receptor agonist on Leydig cells), and HMG (FSH+LH activity). GH peptides have an indirect, modest effect via IGF-1/Leydig potentiation.

What is the most direct peptide for testosterone research?

Kisspeptin-10 is the most pharmacologically precise — activating KISS1R → GnRH pulse → LH → testosterone within 30-60 minutes. The entire HPG axis cascade is intact and testicular function is preserved. HCG bypasses the HPG axis entirely and directly activates Leydig cells — useful when HPG axis suppression is part of the model.

How does HCG increase testosterone differently from kisspeptin-10?

Kisspeptin-10 works upstream — activating the full HPG cascade (GnRH → LH → Leydig). HCG works downstream — directly on the LH receptor at the Leydig cell, bypassing hypothalamus and pituitary. HCG is useful when endogenous LH is suppressed (e.g., during TRT) and Leydig cells need direct stimulation.

Can GH peptides increase testosterone?

Indirectly. GH → IGF-1 → IGF-1R on Leydig cells potentiates LH-stimulated testosterone synthesis. The effect is modest and secondary. GH peptides are not primary testosterone research tools — kisspeptin-10 and HCG are the appropriate compounds for direct testosterone axis research.

Are testosterone peptides the same as anabolic steroids?

No — peptides that stimulate testosterone production (kisspeptin-10, HCG) work by activating the HPG axis or Leydig cells to produce testosterone endogenously. Anabolic steroids (testosterone cypionate, nandrolone) provide exogenous androgenic/anabolic molecules that directly activate the androgen receptor. Mechanistically opposite in terms of HPG axis effects.